223 related articles for article (PubMed ID: 19751820)
1. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway.
Shim GS; Manandhar S; Shin DH; Kim TH; Kwak MK
Free Radic Biol Med; 2009 Dec; 47(11):1619-31. PubMed ID: 19751820
[TBL] [Abstract][Full Text] [Related]
2. Effect of stable inhibition of NRF2 on doxorubicin sensitivity in human ovarian carcinoma OV90 cells.
Manandhar S; Lee S; Kwak MK
Arch Pharm Res; 2010 May; 33(5):717-26. PubMed ID: 20512470
[TBL] [Abstract][Full Text] [Related]
3. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.
Vollrath V; Wielandt AM; Iruretagoyena M; Chianale J
Biochem J; 2006 May; 395(3):599-609. PubMed ID: 16426233
[TBL] [Abstract][Full Text] [Related]
4. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK
Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733
[TBL] [Abstract][Full Text] [Related]
5. Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line.
Tarumoto T; Nagai T; Ohmine K; Miyoshi T; Nakamura M; Kondo T; Mitsugi K; Nakano S; Muroi K; Komatsu N; Ozawa K
Exp Hematol; 2004 Apr; 32(4):375-81. PubMed ID: 15050748
[TBL] [Abstract][Full Text] [Related]
6. Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs.
Tang X; Wang H; Fan L; Wu X; Xin A; Ren H; Wang XJ
Free Radic Biol Med; 2011 Jun; 50(11):1599-609. PubMed ID: 21402146
[TBL] [Abstract][Full Text] [Related]
7. Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stress.
Tan KP; Yang M; Ito S
Mol Pharmacol; 2007 Nov; 72(5):1380-90. PubMed ID: 17724089
[TBL] [Abstract][Full Text] [Related]
8. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
10. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
[TBL] [Abstract][Full Text] [Related]
11. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
12. Activation of Nrf2-mediated oxidative stress response in macrophages by hypochlorous acid.
Pi J; Zhang Q; Woods CG; Wong V; Collins S; Andersen ME
Toxicol Appl Pharmacol; 2008 Feb; 226(3):236-43. PubMed ID: 17980396
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
14. Gamma-tocopheryl quinone, not alpha-tocopheryl quinone, induces adaptive response through up-regulation of cellular glutathione and cysteine availability via activation of ATF4.
Ogawa Y; Saito Y; Nishio K; Yoshida Y; Ashida H; Niki E
Free Radic Res; 2008 Jul; 42(7):674-87. PubMed ID: 18654882
[TBL] [Abstract][Full Text] [Related]
15. Induction of adaptive response and enhancement of PC12 cell tolerance by lipopolysaccharide primarily through the upregulation of glutathione S-transferase A3 via Nrf2 activation.
Omata Y; Saito Y; Fujita K; Ogawa Y; Nishio K; Yoshida Y; Niki E
Free Radic Biol Med; 2008 Nov; 45(10):1437-45. PubMed ID: 18793714
[TBL] [Abstract][Full Text] [Related]
16. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).
Arlt A; Bauer I; Schafmayer C; Tepel J; Müerköster SS; Brosch M; Röder C; Kalthoff H; Hampe J; Moyer MP; Fölsch UR; Schäfer H
Oncogene; 2009 Nov; 28(45):3983-96. PubMed ID: 19734940
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
20. Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
Ong PS; Chan SY; Ho PC
Eur J Pharm Sci; 2012 Feb; 45(3):367-78. PubMed ID: 22178533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]